All News

Porträt Cristina Garcia Caceres

IDO,

Cristina García Cáceres successfully completed her ERC Project: Astrocyte-Neuronal Crosstalk in Obesity and Diabetes (AstroNeuroCrosstalk)

The studies conducted in this ERC project provided a more comprehensive understanding of how the hypothalamus controls energy balance and metabolic adaptations in response to hypercaloric diets, thereby contributing to our understanding of its…

IDR Beta cell Heterogeneity

New Research Findings, Diabetes, IDR, IDO,

Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target

Research targeting the insulin-inhibitory receptor, called inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy. A novel study in mice with diet-induced obesity demonstrates that the knock-out of…

Gender Equality

Diabetes, IDR, IDO, IDM,

Striving for Optimal Healthcare

Sex-Specific Research

Fork with measuring tape around on pink background

Transfer, HI-MAG, IDO,

Science Has Named GLP-1 Drugs the Breakthrough of the Year

2023 has changed the way we treat obesity. A new class of drugs, mimicking a gut hormone called glucagon-like peptide-1 (GLP-1), is reshaping medicine and improving many people’s lives globally. GLP-1 drugs do not only induce significant weight loss,…

GIP im Hirnstamm

New Research Findings, Diabetes, IDO,

Understanding the Role of GIP in Managing Diabetes and Obesity

The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide.…

Matthias Tschöp receives Heinrich Wieland Price 2023

Awards & Grants, Diabetes, IDO,

"Reversing the Pandemic of Obesity and Diabetes"

Heinrich Wieland Prize for Matthias Tschöp: Breakthrough in the battle against obesity and diabetes